Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.
OBJECTIVE: To determine whether the immunogenicity of a single dose infant priming schedule of serogroup C meningococcal (MenC) conjugate vaccine is non-inferior to a two dose priming schedule when followed by a booster dose at age 12 months. DESIGN: Phase IV open label randomised controlled trial c...
Հիմնական հեղինակներ: | Pace, D, Khatami, A, McKenna, J, Campbell, D, Attard-Montalto, S, Birks, J, Voysey, M, White, C, Finn, A, Macloed, E, Faust, S, Kent, A, Heath, P, Borrow, R, Snape, M, Pollard, A |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
BMJ Publishing Group
2015
|
Նմանատիպ նյութեր
-
Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy
: Pace, D, և այլն
Հրապարակվել է: (2016) -
Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination
: De Whalley, P, և այլն
Հրապարակվել է: (2013) -
Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination.
: de Whalley, P, և այլն
Հրապարակվել է: (2013) -
Will booster doses be required for serogroup B meningococcal vaccine?
: McQuaid, F, և այլն
Հրապարակվել է: (2014) -
Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease.
: Pollard, A, և այլն
Հրապարակվել է: (2013)